Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired . via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

News Feed Item

Solos Endoscopy, Inc. Files to Obtain International Quality Control Certification

Solos Endoscopy, Inc. Files to Obtain International Quality Control Certification

BOSTON, MA -- (MARKET WIRE) -- 08/25/06 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) is pleased to announce that Lynette Howard of Lyle Howard Corporation has completed documents to bring the Company's quality control systems into current compliance with the International Organization for Standardization ISO 13485:2003 regulations. The International Organization for Standardization (ISO) is the world's leading developer of International Standards.

ISO is a global network that identifies which international standards are required by business, government, and society. These standards specify the requirements for state-of-the-art products, services, processes, materials, and systems. The standards are also utilized for conformity assessment, managerial and organizational practice. ISO develops them in partnership with the industries that will put them to use, bases them on international input, and disperses them throughout the world.

"We are very pleased to continue with our goal of advancing our regulatory and quality management systems. Solos Endoscopy has built a reputation of quality products and we will look to ensure that our suppliers and manufacturing partners also adhere to our quality control system," stated Robert Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy previously announced that the Company has appointed Irvin Dee Fletcher as Director of Breast Care Products. Mr. Fletcher will be responsible for expanding distribution channels as the Company launches their preventative medical technology products for the early detection of breast cancer.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.

Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Solos Endoscopy, Inc.
Investor Relations

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.